[PDF] Top 20 Ética y política - Una relación obligada?
Has 10000 "Ética y política - Una relación obligada?" found on our website. Below are the top 20 most common "Ética y política - Una relación obligada?".
<p>Sialorrhea in patients with ALS: current treatment options</p>
... national ALS Patient CARE database indicate that over half of ALS patients responded to treatment with atropine, glycopyrrolate or ...of patients affected by chronic neurological ... See full document
177
<p>Chronic prostatitis: current treatment options</p>
... involved patients usually complain of many different symptoms, not limited to “ pure ” prostatodynia but also presenting with: lower urinary tract symptoms (LUTS) with pollakiuria, dysuria, nocturia, urinary ... See full document
21
<p>Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options?</p>
... cycling. Current treatment options for bipolar depression are limited and guidelines vary greatly in their recommendations, re fl ecting gaps and inconsistencies in the current evidence ...some ... See full document
22
Management of patients with resistant hypertension: current treatment options
... of patients with RHTN. Patients with RHTN have higher rates of cardiovascular events and mortality compared with patients with more easily controlled ...in patients with RHTN and often coexist ... See full document
8
<p>Update on Emerging Treatment Options for Primary Biliary Cholangitis</p>
... cirrhosis. Treatment options are currently ...PBC patients with inadequate response or intolerance to ...of treatment options for ... See full document
9
<p>Portosystemic shunts and refractory hepatic encephalopathy: patient selection and current options</p>
... channels and of the shunt as in a “parallel” circuit. The portal venous flow decreases consequently, resulting in portal flow bypassing the liver. The authors reviewed the management results of shunt occlusion in 49 ... See full document
6
<p>Development of treatment options for Chinese patients with advanced squamous cell lung cancer: focus on afatinib</p>
... Key areas of the development of targeted therapies in SqCC of the lung include novel immunotherapies and expansion into the first-line treatment, novel combination regimens with immunotherapies, and agents against ... See full document
16
<p>Revisiting current treatment options for stress urinary incontinence and pelvic organ prolapse: a contemporary literature review</p>
... Urethral bulking is often reserved for women who are unable to tolerate or wish to defer surgical management of SUI. A 2017 meta-analysis of 14 trials in 2004 women receiving various types of bulking agents including ... See full document
104
<p>Selecting treatment options in refractory metastatic colorectal cancer</p>
... of patients with anti-PD-1 therapy, a trial of pembrolizumab was undertaken that enrolled three cohorts of patients: MSI-h colorectal cancers, MSI-h noncolorectal cancers, and microsatel- lite stable ... See full document
5
<p>Management of patients with calciphylaxis: current perspectives</p>
... invasive treatment like maggot ...64 patients, an estimated 1-year survival rate of ...17 patients receiving surgical debride- ment compared with ...topical treatment option, but is only ... See full document
49
<p>Management of Venous Thromboembolism in Children: Current Recommendations and Therapeutic Options</p>
... A therapy duration of 3 months or less (ASH 2C) or 3 months according to CHEST for provoked DVT seems suf fi cient (2C), while unprovoked DVT or PE should be treated for 6 – 12 months (ASH 2C and CHEST 2C), whereas the UK ... See full document
34
<p>A personalized approach to acute myeloid leukemia therapy: current options</p>
... adult patients with AML carry mutations in the FMS like tyrosine kinase 3 (FLT3) ...AML patients, and is one of the driver mutations that presents with high leukemic burden and confers a poor prognosis ... See full document
45
<p>Emerging Treatment Options For Cancer-Associated Cachexia: A Literature Review</p>
... among patients with advanced NSCLC, 46–50 the drug was refused marketing authorization by the European Medicines Agency (EMA) due to undesirable risk-bene fi t pro fi ...of patients, researchers, and ... See full document
12
<p>Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations</p>
... The immunological processes involved in PPP, lead to the accumulation, in the area of the the acrosyringium, of a substantial quantity of granulocytes. 27,31 The cytokines that regulate these processes play a fundamental ... See full document
5
<p>Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects</p>
... cytochrome P 450 (CYP) 3A4 and 2C19, which it strongly ...adjunctive treatment for Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS), while it is being currently investigated in tuberous sclerosis ... See full document
16
<p>Surgical options for control of abdominal pain in chronic pancreatitis patients</p>
... For patients with CP with an in fl ammatory lesion involving the whole pancreas and no pancreatic duct dilation, total pancreatectomy may be the only effective surgical ...for patients with abdominal pain ... See full document
17
<p>Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current Perspectives</p>
... or treatment of patients does not rely only on the limited circle of clinical trial ...early treatment of SMA1 and SMA2 ...early treatment as the time of instauration of a dis- ease-modifying ... See full document
23
<p>Transcranial Direct Current Stimulation in Patients with Anxiety: Current Perspectives</p>
... the treatment of speci fi c phobias, social anxiety disorder, panic disorder, agoraphobia, and generalized anxiety ...in patients with PTSD (one study) and other anxiety disorders (GAD, panic disorder, OCD) ... See full document
16
<p>Bowel Endometriosis: Current Perspectives on Diagnosis and Treatment</p>
... counsel patients appropriately advising that there are no guarantees that symptoms of constipation will improve regardless of whether a more aggressive approach is ... See full document
7
<p>Beyond Ruxolitinib: Fedratinib and Other Emergent Treatment Options for Myelofibrosis</p>
... some patients previously treated with ...treated patients, most of which were ultimately felt not to represent Wernicke ’ s ...future treatment options for MF patients who are ... See full document
46
Related subjects